Search Results for: ARDX
Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures or general lack of interest.
Published:
Last Updated:
After screening the daily 24/7 Wall St. analyst research database, we found five stocks trading under $10 that analysts feel could bring investors solid upside potential.
Published:
Last Updated:
The tide of 2014 initial public offerings (IPO) may be hitting a high-water mark this week with 14 IPOs scheduled to price and begin trading on U.S. markets. According to Renaissance Capital 124 IPOs...
Published:
Last Updated:
Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and could provide investors with some solid upside potential.
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included Beyond Meat, Dun & Bradstreet, Evoqua Water Technologies, Microchip Technology, Skyworks Solutions, SunPower and Texas Instruments.
Published:
Last Updated:
These three biotech companies not only have data that could prove to be huge, but they have been absolutely hammered over the last year and are offering aggressive accounts the best entry points in...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Ardelyx, Juniper, Kroger, Phillips 66, Square, Transocean and Walmart.
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu, Micron Technology, Novavax, PayPal, Pfizer and...
Published:
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Published:
Wednesday's top analyst upgrades, downgrades and initiations included Akamai Technologies, Alibaba, Boeing, Goodyear Tire & Rubber, Lyft, Micron Technology, Nvidia, T-Mobile, Under Armour, Wynn...
Published:
Numbers make my head itch. I still count on my fingers. I have to total figures several times over to get the same result often enough to reassure me that I’m in the ballpark. And that’s...
Published:
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and...
Published:
Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial.
Published:
Last Updated:
ARYx THERAPEUTICS, INC. has filed to raise up to $86.25 million in an IPO under the ticker "ARYX" on NASDAQ. The biotech has secured Morgan Stanley, CIBC World Markets, Jefferies...
Published:
A couple of Cathie Wood's ARK Invest exchange-traded funds sold over 10,000 shares of Alphabet on August 23.
Published: